Correlation Between PetIQ and Neurocrine Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PetIQ and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PetIQ and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PetIQ Inc and Neurocrine Biosciences, you can compare the effects of market volatilities on PetIQ and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PetIQ with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of PetIQ and Neurocrine Biosciences.

Diversification Opportunities for PetIQ and Neurocrine Biosciences

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between PetIQ and Neurocrine is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding PetIQ Inc and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and PetIQ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PetIQ Inc are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of PetIQ i.e., PetIQ and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between PetIQ and Neurocrine Biosciences

Given the investment horizon of 90 days PetIQ Inc is expected to generate 1.78 times more return on investment than Neurocrine Biosciences. However, PetIQ is 1.78 times more volatile than Neurocrine Biosciences. It trades about 0.08 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.01 per unit of risk. If you would invest  1,151  in PetIQ Inc on August 27, 2024 and sell it today you would earn a total of  1,947  from holding PetIQ Inc or generate 169.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.77%
ValuesDaily Returns

PetIQ Inc  vs.  Neurocrine Biosciences

 Performance 
       Timeline  
PetIQ Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Strong
Over the last 90 days PetIQ Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, PetIQ is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.
Neurocrine Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

PetIQ and Neurocrine Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PetIQ and Neurocrine Biosciences

The main advantage of trading using opposite PetIQ and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PetIQ position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.
The idea behind PetIQ Inc and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments